SujitShethMD
Pediatric Hematology & Oncology • New York, NYAssociate Professor, Pediatrics, Columbia University College of Phys & Surg
Overview of Dr. Sheth
Dr. Sujit Sheth is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Seth G.S. Medical College and has been in practice 31 years. Dr. Sheth accepts several types of health insurance, listed below. She is one of 135 doctors at New York-Presbyterian Hospital and one of 37 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Pediatric Hematology & Oncology. She has more than 70 publications and over 500 citings.
Office
3959 Broadway
Columbia University Department Pediatrics
New York, NY 10032Fax+1 212-544-1974
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 1993 - 1996
Seth G.S. Medical CollegeClass of 1988
Certifications & Licensure
NY State Medical License 1997 - 2026- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- High-Tc Susceptometer to Monitor Transfusional Iron Overload Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators' era.Morgan Pines, Dorothy Kleinert, Charlene Thomas, Cheryl Mensah, Khaled M Musallam
Annals of Hematology. 2024-12-14 - 1 citationsRates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data.Sherif M Badawy, Jan Palmblad, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette
Blood Advances. 2024-11-12 - Anemia and iron overload as prognostic markers of outcomes in β-thalassemia.Khaled M Musallam, Sujit Sheth, Maria Domenica Cappellini, Gian Luca Forni, Aurelio Maggio
Expert Review of Hematology. 2024-09-01
Press Mentions
Rates of Severe Neutropenia and Infection Risk in Patients Treated with Deferiprone: 28 Years of DataNovember 1st, 2024- CRISPR Technology to Cure Sickle Cell DiseaseJanuary 20th, 2021
Beta Thalassemia Severity and Impact on Patients' Quality of LifeFebruary 7th, 2020- Join now to see all
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
Great West PPOHealthfirst New York
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
